Authors:
SCHENKER MB
CHRISTIANI D
CORMIER Y
DIMICHWARD H
DOEKES G
DOSMAN J
DOUWES J
DOWLING K
ENARSON D
GREEN F
HEEDERIK D
HUSMAN K
KENNEDY S
KULLMAN G
LACASSE Y
LAWSON B
MALMBERG P
MAY J
MCCURDY S
MERCHANT J
MYERS J
NIEUWENHUIJSEN M
OLENCHOCK S
SAIKI C
SCHWARTZ D
SEIBER J
THORNE P
WAGNER G
WHITE N
XU XP
CHANYEUNG M
Citation: Mb. Schenker et al., RESPIRATORY HEALTH-HAZARDS IN AGRICULTURE, American journal of respiratory and critical care medicine, 158(5), 1998, pp. 1-76
Authors:
CORMIER Y
ISRAELASSAYAG E
BEDARD G
DUCHAINE C
Citation: Y. Cormier et al., HYPERSENSITIVITY PNEUMONITIS IN PEAT MOSS PROCESSING PLANT WORKERS, American journal of respiratory and critical care medicine, 158(2), 1998, pp. 412-417
Authors:
CORMIER Y
LAVIOLETTE M
BEDARD G
DOSMAN J
ISRAELASSAYAG E
Citation: Y. Cormier et al., EFFECT OF ROUTE OF BREATHING ON RESPONSE TO EXPOSURE IN A SWINE CONFINEMENT BUILDING, American journal of respiratory and critical care medicine, 157(5), 1998, pp. 1512-1521
Authors:
SANDLER A
DENHAM C
VONPAWEL J
CORMIER Y
GATZEMEIER U
MATTSON K
MANEGOLD C
GREGOR A
BLATTER J
EINHORN L
Citation: A. Sandler et al., SIGNIFICANTLY HIGHER SURVIVAL WITH GEMCITABINE-CISPLATIN VS CISPLATININ ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC) - FINAL RESULTS FROM ANINTERNATIONAL RANDOMIZED PHASE-III STUDY, Annals of oncology, 9, 1998, pp. 409-409
Citation: A. Dakhama et al., ROLE OF INTERLEUKIN-2 IN THE DEVELOPMENT AND PERSISTENCE OF LYMPHOCYTIC ALVEOLITIS IN FARMERS LUNG, The European respiratory journal, 11(6), 1998, pp. 1281-1286
Authors:
SHEPHERD FA
JOHNSTON MR
PAYNE D
BURKES R
DESLAURIERS J
CORMIER Y
DEBEDOYA LD
OTTAWAY J
JAMES K
ZEE B
Citation: Fa. Shepherd et al., RANDOMIZED STUDY OF CHEMOTHERAPY AND SURGERY VERSUS RADIOTHERAPY FOR STAGE IIIA NON-SMALL-CELL LUNG-CANCER - A NATIONAL-CANCER-INSTITUTE OFCANADA CLINICAL-TRIALS GROUP-STUDY, British Journal of Cancer, 78(5), 1998, pp. 683-685
Authors:
SENTHILSELVAN A
ZHANG Y
DOSMAN JA
BARBER EM
HOLFELD LE
KIRYCHUK SP
CORMIER Y
HURST TS
RHODES CS
Citation: A. Senthilselvan et al., POSITIVE HUMAN HEALTH-EFFECTS OF DUST SUPPRESSION WITH CANOLA OIL IN SWINE BARNS, American journal of respiratory and critical care medicine, 156(2), 1997, pp. 410-417
Citation: E. Israelassayag et Y. Cormier, SURFACTANT MODIFIES THE LYMPHOPROLIFERATIVE ACTIVITY OF MACROPHAGES IN HYPERSENSITIVITY PNEUMONITIS, American journal of physiology. Lung cellular and molecular physiology, 17(6), 1997, pp. 1258-1264
Authors:
CORMIER Y
DUCHAINE C
ISRAELASSAYAG E
BEDARD G
LAVIOLETTE M
DOSMAN J
Citation: Y. Cormier et al., EFFECTS OF REPEATED SWINE BUILDING EXPOSURES ON NORMAL NAIVE SUBJECTS, The European respiratory journal, 10(7), 1997, pp. 1516-1522
Authors:
VIALLET J
STEWART D
SHEPHERD F
AYOUB J
CORMIER Y
DIPIETRO N
STEWARD W
Citation: J. Viallet et al., TALLIMUSTINE IS INACTIVE IN PATIENTS WITH PREVIOUSLY TREATED SMALL-CELL LUNG-CANCER - A PHASE-II TRIAL OF THE NATIONAL-CANCER-INSTITUTE-OF-CANADA CLINICAL-TRIALS-GROUP (VOL 15, PG 367, 1996), Lung cancer, 17(1), 1997, pp. 179-179
Authors:
SHEPHERD FA
CORMIER Y
BURKES R
EVANS WK
GOSS G
KLIMO P
FELD R
TAYLOR M
Citation: Fa. Shepherd et al., PHASE-II TRIAL OF GEMCITABINE AND WEEKLY CISPLATIN FOR ADVANCED NONSMALL CELL LUNG-CANCER, Seminars in oncology, 24(3), 1997, pp. 827-830
Authors:
TREMBLAY GM
SALLENAVE JM
ISRAELASSAYAG E
CORMIER Y
GAULDIE J
Citation: Gm. Tremblay et al., ELAFIN ELASTASE-SPECIFIC INHIBITOR IN BRONCHOALVEOLAR LAVAGE OF NORMAL SUBJECTS AND FARMERS LUNG/, American journal of respiratory and critical care medicine, 154(4), 1996, pp. 1092-1098
Citation: A. Dakhama et al., ALTERED IMMUNOSUPPRESSIVE ACTIVITY OF ALVEOLAR MACROPHAGES IN FARMERSLUNG-DISEASE, The European respiratory journal, 9(7), 1996, pp. 1456-1462
Citation: Y. Cormier et al., REACTIVE AIRWAYS DYSFUNCTION SYNDROME (RADS) FOLLOWING EXPOSURE TO TOXIC GASES OF A SWINE CONFINEMENT BUILDING, The European respiratory journal, 9(5), 1996, pp. 1090-1091
Authors:
DUCHAINE C
ISRAELASSAYAG E
FOURNIER M
CORMIER Y
Citation: C. Duchaine et al., PROINFLAMMATORY EFFECT OF PEDIOCOCCUS-PENTOSACEUS, A BACTERIUM USED AS HAY PRESERVATIVE, The European respiratory journal, 9(12), 1996, pp. 2508-2512
Authors:
SHEPHERD FA
BURKES R
CORMIER Y
CRUMP M
FELD R
STRACK T
SCHULZ M
Citation: Fa. Shepherd et al., PHASE-I DOSE-ESCALATION TRIAL OF GEMCITABINE AND CISPLATIN FOR ADVANCED NON-SMALL-CELL LUNG-CANCER - USEFULNESS OF MATHEMATIC MODELING TO DETERMINE MAXIMUM-TOLERABLE DOSE, Journal of clinical oncology, 14(5), 1996, pp. 1656-1662
Citation: Y. Cormier et al., VIRAL-INFECTION ENHANCES THE RESPONSE TO SACCHAROPOLYSPORA-RECTIVIRGULA IN MICE PRECHALLENGED WITH THIS FARMERS LUNG ANTIGEN, Lung, 174(6), 1996, pp. 399-407
Authors:
VIALLET J
STEWART D
SHEPHERD F
AYOUB J
CORMIER Y
DIPIETRO N
STEWARD W
Citation: J. Viallet et al., TALLIMUSTINE IS INACTIVE IN PATIENTS WITH PREVIOUSLY TREATED SMALL-CELL LUNG-CANCER - A PHASE-II TRIAL OF THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP, Lung cancer, 15(3), 1996, pp. 367-373
Authors:
SHEPHERD FA
BURKES R
CORMIER Y
CRUMP M
FELD R
STRACK T
Citation: Fa. Shepherd et al., PHASE-I TRIAL OF GEMCITABINE AND CISPLATIN IN ADVANCED NON-SMALL-CELLLUNG-CANCER - A PRELIMINARY-REPORT, Lung cancer, 14(1), 1996, pp. 135-144
Authors:
SHEPHERD FA
BURKES RL
CORMIER Y
CRUMP M
FELD R
STRACK T
SCHULZ M
Citation: Fa. Shepherd et al., FINAL RESULTS OF THE CANADIAN PHASE-I DOSE-ESCALATION TRIAL OF GEMCITABINE AND CISPLATIN FOR ADVANCED NONSMALL CELL LUNG-CANCER, Seminars in oncology, 23(5), 1996, pp. 48-54
Authors:
CORMIER Y
ISRAELASSAYAG E
DESMEULES M
LESUR O
Citation: Y. Cormier et al., EFFECT OF CONTACT AVOIDANCE OR TREATMENT WITH ORAL PREDNISOLONE ON BRONCHOALVEOLAR LAVAGE SURFACTANT PROTEIN-A LEVELS IN SUBJECTS WITH FARMERS LUNG, Thorax, 51(12), 1996, pp. 1210-1215
Authors:
BOUCHARD S
MORIN F
BEDARD G
GAUTHIER J
PARADIS J
CORMIER Y
Citation: S. Bouchard et al., FARMERS LUNG AND VARIABLES RELATED TO THE DECISION TO QUIT FARMING, American journal of respiratory and critical care medicine, 152(3), 1995, pp. 997-1002
Authors:
ALBERTI W
ANDERSON G
BARTOLUCCI A
BELL D
VILLALBA JB
BRODIN O
CARDIELLO C
CARTEI F
CARTEI G
CELLERINO R
CHASTANG C
CORMIER Y
COX JD
CRINO L
CROWLEY J
DAUTZENBERG B
DEPIERRE A
DIETEMANN A
DILLMAN RO
DOI O
FELD R
FIGLIN R
GANZ PA
GREEN MR
GREGOR A
HELLE PA
HERNDON JE
HITOMI S
HOST H
IMAIZUMI M
JETT JR
JOHNSON D
KAASA S
KIMURA H
KLASTERSKY J
KONDO H
KREISMAN H
KRIS MG
KUNISHIMA K
KUWAHARA O
LAD TE
LAING AH
MACBETH F
MASAOKA A
MATTSON K
MINATEL E
MIRA JG
MORI T
MOUNTAIN CF
NIEDERLE N
NIIRANEN A
NOU E
PAGE W
PATER J
PIANTADOSI S
PISTERS KMW
PYRHONEN S
QUOIX E
RAPP E
ROWELL NP
SAHMOUD T
SAWAMURA K
SCHALLIER DCC
SCOTT C
SIMPSON J
STAGG M
TERAMATSU T
TROVO MG
TSUCHIYA R
TUMMARELLO D
VANHOUTTE P
VANZANDWIJK N
VINCENT RG
WADA H
WHITE JE
WILLIAMS CJ
WOODS RL
YAMAGUCHI Y
ARRIAGADA R
CARTMELLDAVIES J
GIRLING DJ
LECHEVALIER T
MARSONI S
PARMAR MKB
PIGNON JP
REKACEWICZ C
SOUHAMI RL
STEWART LA
TARAYRE M
TINAZZI A
TONI V
Citation: W. Alberti et al., CHEMOTHERAPY IN NON-SMALL-CELL LUNG-CANCER - A METAANALYSIS USING UPDATED DATA ON INDIVIDUAL PATIENTS FROM 52 RANDOMIZED CLINICAL-TRIALS, BMJ. British medical journal, 311(7010), 1995, pp. 899-909
Authors:
SHEPHERD F
CORMIER Y
BURGES R
CRUMP M
STRACK T
Citation: F. Shepherd et al., PHASE-I TRIAL OF GEMCITABINE (GEM) AND CISPLATIN (CP) FOR NON-SMALL-CELL LUNG-CANCER (NSCLC), European journal of cancer, 31A, 1995, pp. 1080-1080